When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization FDA Moves to Reevaluate Several Peptides American Med Spa Association BPC 157: Miracle Healing Peptide or Hidden Danger? Peptides Lack Reliable Safety Information, Watchdog Warns FDA's Overreach on Compounded Peptides